Latest News for: ros1

Edit

Nuvalent to Present New Preclinical Data on ALK-Selective Inhibitor, Neladalkib, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2025

PR Newswire 25 Mar 2025
Crystal structure of drug-resistant ROS1 G2032R in complex with zidesamtinib, a clinical-stage ROS1 inhibitor with best-in-class potentialAuthors. Joseph M ... currently available ROS1 inhibitors.
  • 1
×